{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T17:55:32Z","timestamp":1790618132329,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T00:00:00Z","timestamp":1779494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"vor","delay-in-days":54,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Research Institute for Gastroenterology and liver diseases (RIGLD), Shahid Beheshti University of Medical Sciences (SBMU)."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Complement Med Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Disruption of the intestinal epithelial barrier is a hallmark of inflammatory bowel disease (IBD). Although probiotics and postbiotics are increasingly recognized as potential therapeutic approaches, treatment efficacy is often influenced by patient-specific variability.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      In this study, intestinal inflammation was modeled by exposing HT-29 cells to fecal supernatants (FS) derived from three patients with ulcerative colitis (UC). The expression of pro-inflammatory (\n                      <jats:italic>IL-8<\/jats:italic>\n                      ) and barrier-associated (\n                      <jats:italic>Claudin-1<\/jats:italic>\n                      ,\n                      <jats:italic>MUC2<\/jats:italic>\n                      ) genes was assessed by real-time PCR. Subsequently, the restorative effects of different preparations of\n                      <jats:italic>Lactobacillus helveticus<\/jats:italic>\n                      SBT2171, including live bacteria, cell-free supernatant, and debris-containing supernatant, were evaluated at 24 and 48\u00a0h.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      FS exposure significantly upregulated\n                      <jats:italic>IL-8<\/jats:italic>\n                      expression while downregulating\n                      <jats:italic>Claudin-1<\/jats:italic>\n                      and\n                      <jats:italic>MUC2<\/jats:italic>\n                      , thereby recapitulating IBD-associated epithelial disruption. Treatment with\n                      <jats:italic>L. helveticus<\/jats:italic>\n                      preparations partially restored barrier-related gene expression in a patient- and treatment-dependent manner. Live bacteria induced transient or sustained\n                      <jats:italic>Claudin-1<\/jats:italic>\n                      upregulation depending on the FS source, whereas the cell-free supernatant demonstrated broader and more durable restorative effects across distinct inflammatory contexts. In contrast, debris-containing preparations exerted limited or even suppressive effects, particularly on\n                      <jats:italic>MUC2<\/jats:italic>\n                      expression.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      These findings demonstrate that the barrier-restorative effects of\n                      <jats:italic>L. helveticus in vitro<\/jats:italic>\n                      is not uniform but shaped by the unique inflammatory and microbial environment of each patient. Collectively, our results support the potential of postbiotic formulations as safer and effective modulators of epithelial barrier repair and underscore the need for personalized strategies in microbiota-based therapies for IBD.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12906-026-05416-0","type":"journal-article","created":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T04:46:53Z","timestamp":1779511613000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Personalized barrier recovery induced by Lactobacillus helveticus SBT2171 in an In Vitro model of ulcerative colitis-derived fecal supernatants"],"prefix":"10.1186","volume":"26","author":[{"given":"Melika","family":"Khademi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nesa","family":"Kazemifard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohadese","family":"Fathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9941-733X","authenticated-orcid":false,"given":"Maryam","family":"Farmani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0359-8653","authenticated-orcid":false,"given":"Shaghayegh","family":"Baradaran Ghavami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binazir","family":"Khanabadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shabnam","family":"Shahrokh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,23]]},"reference":[{"key":"5416_CR1","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3390\/ani12020145","volume":"12","author":"M Giery\u0144ska","year":"2022","unstructured":"Giery\u0144ska M, Szulc-D\u0105browska L, Struzik J, Mielcarska MB, Gregorczyk-Zboroch KP. Integrity of the intestinal barrier: the involvement of epithelial cells and microbiota\u2014a mutual relationship. Animals. 2022;12:145.","journal-title":"Animals"},{"key":"5416_CR2","first-page":"383629","volume":"10","author":"AA Bhat","year":"2019","unstructured":"Bhat AA, Uppada S, Achkar IW, Hashem S, Yadav SK, Shanmugakonar M, et al. Tight junction proteins and signaling pathways in cancer and inflammation: a functional crosstalk. Front Physiol. 2019;10:383629.","journal-title":"Front Physiol"},{"key":"5416_CR3","doi-asserted-by":"publisher","DOI":"10.1080\/21688370.2024.2390218","author":"N Kazemifard","year":"2024","unstructured":"Kazemifard N, Golestani N, Jahankhani K, Farmani M, Ghavami SB. Ulcerative colitis: the healing power of macrophages. Tissue Barriers. 2024;13(2):2390218. https:\/\/doi.org\/10.1080\/21688370.2024.2390218","journal-title":"Tissue Barriers"},{"key":"5416_CR4","doi-asserted-by":"crossref","unstructured":"Yu S, Sun Y, Shao X, Zhou Y, Yu Y, Kuai C et al. Leaky gut in IBD: intestinal barrier\u2013gut microbiota interaction. J Microbiol Biotechnol. 2022;32(7):825.","DOI":"10.4014\/jmb.2203.03022"},{"key":"5416_CR5","doi-asserted-by":"crossref","unstructured":"Zheng L, Duan SL. Molecular regulation mechanism of intestinal stem cells in mucosal injury and repair in ulcerative colitis. World J Gastroenterol. 2023;29(16):2380.","DOI":"10.3748\/wjg.v29.i16.2380"},{"key":"5416_CR6","doi-asserted-by":"crossref","unstructured":"Okumura R, Takeda K. The role of the mucosal barrier system in maintaining gut symbiosis to prevent intestinal inflammation. Semin Immunopathol. 2025;47 (1):2.","DOI":"10.1007\/s00281-024-01026-5"},{"key":"5416_CR7","doi-asserted-by":"crossref","unstructured":"Ramos GP, Papadakis KA. Mechanisms of disease: inflammatory bowel diseases. Mayo Clin Proc. 2019;94:155\u201365.","DOI":"10.1016\/j.mayocp.2018.09.013"},{"key":"5416_CR8","doi-asserted-by":"publisher","DOI":"10.1080\/21688370.2025.2458784","author":"K Basiji","year":"2025","unstructured":"Basiji K, Kazemifard N, Farmani M, Jahankhani K, Ghavami SB, Fallahnia A, et al. Fistula in Crohn\u2019s disease: classification, pathogenesis, and treatment options. Tissue Barriers. 2025;13(3):2458784. https:\/\/doi.org\/10.1080\/21688370.2025.2458784","journal-title":"Tissue Barriers"},{"key":"5416_CR9","doi-asserted-by":"crossref","unstructured":"Hou JJ, Li Y, Wang X, Zhang T, Liu Y et al. The proteolytic activity in inflammatory bowel disease: insight from gut microbiota. Microb Pathog. 2024;188:106560.","DOI":"10.1016\/j.micpath.2024.106560"},{"key":"5416_CR10","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1097\/MIB.0000000000000081","volume":"20","author":"P Meelu","year":"2014","unstructured":"Meelu P, Singh A, Sharma R, et al. Impaired innate immune function associated with fecal supernatant from Crohn\u2019s disease patients: insights into potential pathogenic role of the microbiome. Inflamm Bowel Dis. 2014;20:1139\u201346.","journal-title":"Inflamm Bowel Dis"},{"key":"5416_CR11","doi-asserted-by":"crossref","unstructured":"Gou HZ, Zhang YL, Ren LF, Li ZJ, Zhang L. How do intestinal probiotics restore the intestinal barrier? Front Microbiol. 2022;13:929346.","DOI":"10.3389\/fmicb.2022.929346"},{"key":"5416_CR12","doi-asserted-by":"publisher","first-page":"3265","DOI":"10.1007\/s12013-024-01356-z","volume":"82","author":"AA Sendani","year":"2024","unstructured":"Sendani AA, Al-Saleh AA, Alshammari GM, et al. Exploring the anti-inflammatory and antioxidative potential of selenium nanoparticles biosynthesized by Lactobacillus casei 393 on an inflamed Caco-2 cell line. Cell Biochem Biophys. 2024;82:3265\u201376.","journal-title":"Cell Biochem Biophys"},{"key":"5416_CR13","doi-asserted-by":"crossref","unstructured":"Zheng Y, Li X, Wang Y et al. Probiotics fortify intestinal barrier function: a systematic review and meta-analysis of randomized trials. Front Immunol. 2023 ;14:1143548.","DOI":"10.3389\/fimmu.2023.1143548"},{"key":"5416_CR14","doi-asserted-by":"crossref","unstructured":"Chelladhurai K, Ayyash M, Turner MS, Kamal-Eldin A. Lactobacillus helveticus: health effects, current applications, and future trends in dairy fermentation. Trends Food Sci Technol. 2023;136:159-68.","DOI":"10.1016\/j.tifs.2023.04.013"},{"key":"5416_CR15","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1002\/jsfa.13721","volume":"105","author":"S Wang","year":"2025","unstructured":"Wang S, Wang P, Wang D, Shen S, Wang Y, Li H, et al. Postbiotics in inflammatory bowel disease: efficacy, mechanism, and therapeutic implications. J Sci Food Agric. 2025;105:721\u201334.","journal-title":"J Sci Food Agric"},{"key":"5416_CR16","doi-asserted-by":"crossref","unstructured":"Caminero A, Guzman M, Libertucci J, Lomax AE. The emerging roles of bacterial proteases in intestinal diseases. Gut Microbes. 2023 ;15(1):2181922.","DOI":"10.1080\/19490976.2023.2181922"},{"key":"5416_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/pcmedi\/pbae023","volume":"7","author":"L Ju","year":"2024","unstructured":"Ju L, Suo Z, Lin J, Liu Z. Fecal microbiota and metabolites in the pathogenesis and precision medicine for inflammatory bowel disease. Precis Clin Med. 2024;7:1\u201311.","journal-title":"Precis Clin Med"},{"key":"5416_CR18","doi-asserted-by":"crossref","unstructured":"Alizadeh A, Akbari P, Garssen J, Fink-Gremmels J, Braber S. Epithelial integrity, junctional complexes, and biomarkers associated with intestinal functions. Tissue Barriers. 2021 ;10(3):1996830.","DOI":"10.1080\/21688370.2021.1996830"},{"key":"5416_CR19","doi-asserted-by":"crossref","unstructured":"Yao D, Dai W, Dong M, Dai C, Wu S. MUC2 and related bacterial factors: therapeutic targets for ulcerative colitis. EBioMedicine. 2021;74.","DOI":"10.1016\/j.ebiom.2021.103751"},{"key":"5416_CR20","doi-asserted-by":"crossref","unstructured":"Kang Y, Park H, Choe BH, Kang B. The role and function of mucins and its relationship to inflammatory bowel disease. Front Med (Lausanne). 2022 ;9:848344.","DOI":"10.3389\/fmed.2022.848344"},{"key":"5416_CR21","doi-asserted-by":"publisher","first-page":"1228283","DOI":"10.3389\/fcell.2023.1228283","volume":"11","author":"K Iyer","year":"2023","unstructured":"Iyer K, Erkert L, Becker C. Know your neighbors: microbial recognition at the intestinal barrier and its implications for gut homeostasis and inflammatory bowel disease. Front Cell Dev Biol. 2023;11:1228283.","journal-title":"Front Cell Dev Biol"},{"key":"5416_CR22","doi-asserted-by":"crossref","unstructured":"Dabek M, Ferrier L, Annahazi A, B\u00e9zirard V, Polizzi A et al. Intracolonic infusion of fecal supernatants from ulcerative colitis patients triggers altered permeability and inflammation in mice: role of cathepsin G and protease. Inflamm Bowel Dis. 2011;17(6):1409-14.","DOI":"10.1002\/ibd.21454"},{"key":"5416_CR23","doi-asserted-by":"crossref","unstructured":"Gorreja F, Bendix M, Rush STA, Maasfeh L, Savolainen O et al. Fecal supernatants from patients with Crohn\u2019s disease induce inflammatory alterations in M2 macrophages and fibroblasts. Cells. 2023;13(1):60.","DOI":"10.3390\/cells13010060"},{"key":"5416_CR24","doi-asserted-by":"crossref","unstructured":"Jakubczyk D, Leszczy\u0144ska K, G\u00f3rska S. The effectiveness of probiotics in the treatment of inflammatory bowel disease\u2014a critical review. Nutrients. 2020;12(7):1973.","DOI":"10.3390\/nu12071973"},{"key":"5416_CR25","doi-asserted-by":"crossref","unstructured":"Taverniti V, Guglielmetti S. Health-promoting properties of Lactobacillus helveticus. Front Microbiol. 2012;3:392.","DOI":"10.3389\/fmicb.2012.00392"},{"key":"5416_CR26","doi-asserted-by":"crossref","unstructured":"Yue Y, Zhang J, Wang L et al. Effects of Lactobacillus acidophilus KLDS1.0901 on proliferation and apoptosis of colon cancer cells. Front Microbiol. 2022;12:788040.","DOI":"10.3389\/fmicb.2021.788040"},{"key":"5416_CR27","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1053\/j.gastro.2017.03.056","volume":"153","author":"NJ Samadder","year":"2017","unstructured":"Samadder NJ, Burt RW, Toydemir RM. Developmental delay and colon polyposis. Gastroenterology. 2017;153:908\u20139.","journal-title":"Gastroenterology"},{"key":"5416_CR28","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.bbrc.2012.01.003","volume":"418","author":"K Essafi-Benkhadir","year":"2012","unstructured":"Essafi-Benkhadir K, Refes Y, et al. Quince (Cydonia oblonga Miller) peel polyphenols modulate LPS-induced inflammation in human THP-1-derived macrophages through NF-\u03baB, p38MAPK and Akt inhibition. Biochem Biophys Res Commun. 2012;418(1):180-5.","journal-title":"Biochem Biophys Res Commun"},{"key":"5416_CR29","doi-asserted-by":"crossref","unstructured":"Alipour S, Ghorbani E, Khazaei M et al. Anti-inflammatory effects of Lactobacillus helveticus and Arthrospira platensis on colonic cells inflamed by Crohn\u2019s disease-associated Escherichia coli. BMC Mol Cell Biol. 2025;26(1):20.","DOI":"10.1186\/s12860-025-00545-9"},{"key":"5416_CR30","doi-asserted-by":"crossref","unstructured":"Jeffrey MP, Strap JL, Taggart HJ, Green-Johnson JM. Lactobacillus rhamnosus R0011 and Lactobacillus helveticus R0389 is mediated by secreted bioactive molecules. Front Immunol. 2018;9:2639.","DOI":"10.3389\/fimmu.2018.02639"},{"key":"5416_CR31","doi-asserted-by":"publisher","first-page":"317","DOI":"10.3920\/BM2017.0097","volume":"9","author":"J Alard","year":"2018","unstructured":"Alard J, Peucelle V, Boutillier D, Breton J, Kuylle S, et al. New probiotic strains for inflammatory bowel disease management identified by combining in vitro and in vivo approaches. Benef Microbes. 2018;9(2):317-32.","journal-title":"Benef Microbes"},{"key":"5416_CR32","doi-asserted-by":"crossref","unstructured":"Rezai S, Ghorbani E, Khazaei M, Nazari SE, Rahmani F et al. Evaluation recovery of ulcerative colitis with a Lactobacillus cocktail derived from traditional dairy products: in vivo study. Adv Biomed Res. 2024;13 (1):85 .","DOI":"10.4103\/abr.abr_157_24"},{"key":"5416_CR33","doi-asserted-by":"crossref","unstructured":"De Marco S, Sichetti M, Muradyan D, Piccioni M, Traina G et al. Probiotic cell-free supernatants exhibited anti-inflammatory and antioxidant activity on human gut epithelial cells and macrophages stimulated with LPS. Evid Based Complement Alternat Med. 2018;2018(1):1756308.","DOI":"10.1155\/2018\/1756308"},{"key":"5416_CR34","doi-asserted-by":"crossref","unstructured":"Yamashita M, Saito T et al. Preventive effect of Lactobacillus helveticus SBT2171 on collagen-induced arthritis in mice. Front Microbiol. 2017;8:1159.","DOI":"10.3389\/fmicb.2017.01159"}],"container-title":["BMC Complementary Medicine and Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12906-026-05416-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-026-05416-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-026-05416-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T08:10:48Z","timestamp":1784189448000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12906-026-05416-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,23]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5416"],"URL":"https:\/\/doi.org\/10.1186\/s12906-026-05416-0","relation":{},"ISSN":["2662-7671"],"issn-type":[{"value":"2662-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,23]]},"assertion":[{"value":"8 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted in accordance with the ethical principles outlined in the Declaration of Helsinki and its subsequent revisions. All procedures involving human participants and the use of human-derived materials complied with institutional and national research ethics guidelines. Ethical approval for the study was obtained from the Ethics Committee of Shahid Beheshti University of Medical Sciences (approval code: IR.SBMU.RIGLD.REC.1401.007). Written informed consent was obtained from all participants prior to sample collection and data analysis.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"228"}}